Results 251 to 260 of about 1,097,417 (389)

Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis.

Journal of the American College of Cardiology, 2012
Peter K. Smith, Lawrence T. Goodnough, Jerrold H. Levy, Robert S. Poston, Mary A Short, G. Weerakkody, L. Lenarz   +6 more
semanticscholar   +1 more source

Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir

British Journal of Pharmacology, EarlyView.
Background and Purpose Human adenovirus (HAdV) causes respiratory or gastrointestinal tract infections depending on the virus subtype. While HAdV infections are generally self‐limiting in immunocompetent people, they can result in significant morbidity and mortality in immunocompromised adults and children.
Mohamed Zamzamy, Sophie Post, Wing Hang Ip, Elin Hahlin, Sebastian Kühn, Andrea Pirosu, Christian Conze, Martin Baumdick, Hamburg Intestinal Study Group, Madeleine J. Bunders, Britta F. Zecher, Angelique Hoelzemer, Stephan Linder, Niklas Arnberg, Thomas Dobner, Marcus Altfeld, Sebastian Schloer   +16 more
wiley   +1 more source

The Effect of Statins on Bleeding in Isolated Coronary Artery Bypass Grafting Statins in CABG. [PDF]

J Clin Med
Karaarslan M, Beyazal OF, Kayalar N, Yanartas M.   +3 more
europepmc   +1 more source

Rescue Therapy With Quad Zygoma After Failure of Full‐Arch Implant Rehabilitation: A Retrospective Study With a Mean Follow‐Up of 8 Years

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To evaluate the long‐term clinical outcomes of quad zygomatic implants (ZIs) as a rescue therapy for patients with failed full‐arch implant rehabilitation in the maxilla due to advanced peri‐implantitis. Material and Methods This was a retrospective cohort study of all patients treated with the Quad Zygoma Protocol. Primary outcomes
Shengchi Fan, Wenjie Zhou, Bilal Al‐Nawas, Eduard Valmaseda‐Castellón, Rubén Davó   +4 more
wiley   +1 more source

Complete Revascularization in Coronary Artery Bypass Grafting: Separating the Wheat from the Chaff. [PDF]

J Chest Surg
Hwang HY.
europepmc   +1 more source

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Venous external support enhanced coronary artery bypass grafting: a multicentric cohort experience. [PDF]

J Cardiothorac Surg
Weltert LP, Sandner S, Centofanti P, Fusca S, Pljakova M, Lodo V, Sebastiano V, De Paulis R.   +7 more
europepmc   +1 more source

Reactivity of the human internal thoracic artery to vasodilators in coronary artery bypass grafting [PDF]

, 2005
Reza Motallebzadeh, Olaf Wendler
openalex   +1 more source

Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Background Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.
Changyuan Yang, Petra Denig, Lynne Chepulis, Ryan G. Paul, Jung‐Im Shin, Ron T. Gansevoort, Priya Vart   +6 more
wiley   +1 more source

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the real‐world effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in an insured US population.
Lauren Wilson, Zhenxiang Zhao, Victoria Divino, Matthew Bassan, Bríain Ó. Hartaigh, Signe Stensen, Kerem Ozer   +6 more
wiley   +1 more source